GlaukomAIcareNCT07668193
GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Start date pushed from Oct 2026 to Dec 2026 Show 4 more changesShow less
- Eligibility criteria expanded, about 11 words
- Secondary endpoints: details revised at 2 of 2 entries
- Publications: details revised at 6 of 6 entries
- Study description expanded, about 2 words
- Notable Start date: Jun 2026 to Oct 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Diagnostic Accuracy of GlaukomAI - Sensitivity and Specificity
Timeframe: At enrollment visit (single visit, or two consecutive visits within 1 week)
Secondary (2)
Referral Accuracy of GlaukomAI vs. Non-Specialist Ophthalmologists
Diagnostic Agreement - Cohen's Kappa
Arms and interventions
Glaucoma PatientsOther
Participants with diagnosed glaucoma (primary open-angle, primary angle-closure or secondary glaucoma) undergoing standard ophthalmological examination and AI-based image analysis.
Healthy ControlsOther
Participants without ocular pathology and with normal ophthalmological examination undergoing standard ophthalmological examination and AI-based image analysis.
Devices: GlaukomAI (Sens-vue GlaukomAI)